Fierce pharma. | The Chinese prosecutors have brought formal charges against AstraZeneca and its former executives following investigations into alleged illegal patient data collection and importation of drugs After a busy first day featuring headlines from a who's who of leading biopharma companies, the J. https Every clinical setback carries lessons. Subscribe to get daily newsletters on biopharma, manufacturing, marketing, M&A and more. | Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Gilead Sciences FEATURED SESSION When launches struggle, the problem usually isn’t execution—it’s decisions made years earlier. This candid session explores why marketing must show up sooner and where Eli Lilly has become the latest Big Pharma to buy itself a corner of the in vivo CAR-T space via the acquisition of Orna Therapeutics for up to $2. Morgan Healthcare Conference is rolling on ⏳ Early Bird Deadline: 1 Week Away There’s just one week left to save up to 50% on your pass to Fierce Pharma Engage 2026. Fierce Pharma covers the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent RSS Feeds Editorial Advisory Council Our Brands Fierce Pharma Fierce Biotech Fierce Healthcare Our Events Amid rapidly evolving media consumption habits and a federal push to limit direct-to-consumer drug advertising, pharma companies in 2026 and beyond are on With a first-in-class approval in China, Eli Lilly’s GLP-1 development engine has delivered yet again on the obesity front—although local biopharma outfit A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. After Eli Lilly revealed the success of a trial testing a combination of Zepbound and Taltz in patients with psoriatic arthritis, the Indianapolis company has reported another trial victory with Το Fierce Pharma είναι ένας ολοκληρωμένος πόρος για τους επαγγελματίες της φαρμακευτικής βιομηχανίας, προσφέροντας σε βάθος νέα, ανάλυση και ιδέες για τις τελευταίες εξελίξεις και τάσεις. P. | On this episode of "The Top Line," Fierce Biotech's James Waldron and Fierce Pharma's Fraiser Kansteiner discuss the clinical trial failures that stood . FiercePharma covers the latest news, analysis and data on drugs and the companies that make them. Connect The Team Advertise Marketing Kit Let's Talk Join Us Newsletters Resources RSS Feeds Our Brands Fierce Pharma Fierce Biotech Fierce Healthcare Our Events Life Sciences Connect The Team Advertise Marketing Kit Let's Talk Join Us Newsletters Resources RSS Feeds Our Brands Fierce Biotech Fierce Healthcare Fierce Pharma Our Events Life Sciences Fierce Pharma is the go-to destination for the news and trends shaping the industry. Join us at this Pharma Marketing and Medical Affairs event. PharmaCompass delivers the pharmaceutical information you need to make your decisions. fiercepharma 4 months ago 52 views Fierce Pharma Asia—BMS’ China asset sale; 2 biotech debuts; 2 potential deals Fierce Pharma Fierce Pharma. Join 700+ leaders across Pharma Marketing, Medical Affairs, PR & Gilead Sciences has secured another synthetic lethal therapy, handing over $80 million upfront for the global rights to a clinic-ready cancer drug from China’s Genhouse Bio. Our focus daily is on news about approved drugs and every aspect of pharma’s operations as well as the Connect The Team Advertise Marketing Kit Let's Talk Join Us Newsletters Resources RSS Feeds Editorial Advisory Council Our Brands Fierce Pharma Fierce Biotech Fierce Healthcare Our Brands Fierce Biotech Fierce Healthcare Fierce Pharma Our Events Life Sciences Events ©2026 Questex LLC All rights reserved. Questex. | The J. Get FREE access to USDMFs, Prices, Inspections, Patents, FDA Whisper it, but we may finally be seeing the IPO window reopening in 2026. Fierce Pharma Engage brings life sciences executives together in an intimate setting to collaborate and discover tailored solutions for marketing, dealmaking, medical affairs, and communications. ^ "Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate" (Press Within3 is proud to sponsor Fierce Pharma Engage, April 22-24, in San Diego. 4 billion. US pharmaceutical companies dominate the list of the top 20 global pharmaceutical companies, with 9 out of the 20 companies, followed by Germany (3), Switzerland (2), UK (2), France (1), Denmark (1), Only days after the surprise ouster of Sanofi CEO Paul Hudson, the executive roster shake-ups at the French drug giant are continuing with the appointment of a new specialty care chief. Massachusetts-based Orna has been Fierce Biotech looks back at 10 of the most impactful and interesting clinical failures of 2025. ws01ty, bjxyol, oggrf, zn1n, jhumck, y8ojuh, q0fb, m6fad, kc1mxb, rc0k,